CVS Health Corporation CVS
Set alert
At close · Oct 30
After hours · Oct 30, 4:33 PM ET
- YTD
- +13.72%
- 1 year
- +17.68%
- Open
- 91.95
- Prev close
- 90.33
- Mkt cap
- 115.43B
- Vol
- 8.19M
- Avg vol
- 7.94M
- EPS
- 3.80
- P/E
- 23.75
- Div yield
- 2.94%
More statistics
- Low
- 89.90
- High
- 91.95
- Forward P/E
- 10.60
- Beta
- 0.60
- Short ratio
- 1.63
- Inst. own
- 91.08%
- Dividend
- 2.66
- Ex-div date
- Oct 21, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 91.29
- 200-d avg
- 88.73
- 1y target
- 115.48
3M chart
Events in this range
- Aug 5, 2026Earnings: 2.58; estimate 1.85; surprise 39.46%
- Aug 6, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Aug 6, 2026Rating: UBS · Buy → Buy
- Aug 12, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 19, 2026Rating: Argus Research · Buy → Buy
- Sep 3, 2026Rating: UBS · Buy → Buy
- Oct 12, 2026Rating: Leerink Partners · Outperform → Outperform
- Oct 22, 2026Dividend: 0.665
Signals (13)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 1 day ago |
| SMA: Bearish | Oct 27, 2026 | 4 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 31, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
Key statistics
- Market cap
- 115.70B
- Enterprise value
- 178.07B
- Trailing P/E
- 23.81
- Forward P/E
- 10.60
- PEG ratio
- 0.21
- Price / sales
- 0.28
- Price / book
- 1.45
- EPS (TTM)
- 3.80
- Beta
- 0.60
- Dividend yield
- 2.94%
- Payout ratio
- 70.00%
- Profit margin
- 1.18%
- Revenue (TTM)
- 412.64B
- Revenue growth
- 7.10%
- Free cash flow
- 8.08B
- Total cash
- 13.96B
- Total debt
- 76.31B
- Return on equity
- 6.21%
- Shares outstanding
- 1.28B
- Short % of float
- 1.28%
- 50-day average
- 91.29
- 200-day average
- 88.73
Analyst view
Consensus: strong buy
- Target (low)
- 103.00
- Target (mean)
- 115.48
- Target (high)
- 145.00
- Strong buy7
- Buy18
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 1.65.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 1.65 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 1.85 | 2.58 | +0.73 | +39.46% |
| May 6, 2026 | Mar 31, 2026 | 2.18 | 2.57 | +0.39 | +17.89% |
| Feb 10, 2026 | Dec 31, 2025 | 1.00 | 1.09 | +0.09 | +9.00% |
| Oct 29, 2025 | Sep 30, 2025 | 1.37 | 1.60 | +0.23 | +16.79% |
| Jul 31, 2025 | Jun 30, 2025 | 1.46 | 1.81 | +0.35 | +23.97% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Leerink Partners | main | Outperform | Outperform |
| Sep 3, 2026 | UBS | main | Buy | Buy |
| Aug 19, 2026 | Argus Research | main | Buy | Buy |
| Aug 12, 2026 | JP Morgan | main | Overweight | Overweight |
| Aug 6, 2026 | UBS | main | Buy | Buy |
| Aug 6, 2026 | Evercore ISI Group | main | Outperform | Outperform |
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- cvshealth.com
News
- Countdown to CVS Health (CVS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
- Drug Middlemen Face New Transparency Rules as Trump Administration Targets Hidden Fees, Rebates and Spread Pricing: Report
- CVS Q3 Preview: Accelerating Growth, Near 3% Yield, Meaningful Upside Long-Term
- Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
- CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
- Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
- CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
- Should You Buy CVS Health Stock While It's Under $100?
- CVS Health Q3 Earnings Preview: How to Approach the Stock?
- Aetna Provider Survey Shows Payer-Provider Trust Remains Strong; Providers say Reducing Fraud can Significantly Lower Health Care Costs
Your note
Sign in to keep a note on CVS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN C DAVID II | Director | Stock Award(Grant) | May 13, 2026 | 129,316 |
| CAPOZZI HEIDI B | Officer | Stock Award(Grant) | Mar 30, 2026 | 97,473 |
| COMPTON-PHILLIPS AMY | Officer | Stock Award(Grant) | Mar 30, 2026 | 58,660 |
| COWHEY THOMAS F. | Chief Financial Officer | Stock Award(Grant) | Mar 31, 2025 | 91,297 |
| FARAH ROGER N | Director | Stock Award(Grant) | Nov 28, 2024 | 54,249 |
| JOYNER JOHN DAVID | Chief Executive Officer | Stock Award(Grant) | Mar 30, 2026 | 231,209 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.63% | 123,223,409 | 11.15B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.51% | 83,315,369 | 7.54B | Jun 29, 2026 |
| Capital World Investors | 5.86% | 74,951,955 | 6.78B | Jun 29, 2026 |
| State Street Corporation | 4.71% | 60,283,408 | 5.45B | Jun 29, 2026 |
| Dodge & Cox Inc. | 3.91% | 50,012,765 | 4.52B | Jun 29, 2026 |
| Wellington Management Group, LLP | 2.64% | 33,801,113 | 3.06B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 40,502,867 | 3.66B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 33,064,695 | 2.99B | Jun 29, 2026 |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 2.48% | 31,708,094 | 2.87B | Jun 29, 2026 |
| WASHINGTON MUTUAL INVESTORS FUND | 2.47% | 31,634,083 | 2.86B | Sep 29, 2026 |
| Income Fund of America | 1.85% | 23,692,996 | 2.14B | Sep 29, 2026 |
| AMERICAN BALANCED FUND | 1.33% | 17,065,948 | 1.54B | Sep 29, 2026 |